Chronic lithium treatment increased intracellular S100ß levels in rat primary neuronal culture.
S100ß a neurotrophic factor mainly released by astrocytes, has been implicated in the pathogenesis of bipolar disorder. Thus, lithium may exert its neuroprotective effects to some extent through S100ß. Furthermore, the possible effects of lithium on astrocytes as well as on interactions between neurons and astrocytes as a part of its mechanisms of actions are unknown. This study was undertaken to determine the effect of lithium on S100β in neurons, astrocytes and a mixture of neurons and astrocytes. Rat primary astrocyte, neuronal and mixed neuro-astroglia cultures were prepared from cortices of 18-day's embryos. Cell cultures were exposed to lithium (1mM) or vehicle for 1day (acute) or 7 days (chronic). RT-PCR and ELISA determined S100β mRNA and intra- and extracellular protein levels. Chronic lithium treatment significantly increased intracellular S100β in neuronal and neuro-astroglia cultures in comparison to control cultures (P<0.05). Acute and chronic lithium treatments exerted no significant effects on intracellular S100β protein levels in astrocytes, and extracellular S100β protein levels in three studied cultures as compared to control cultures. Acute and chronic lithium treatments did not significantly alter S100β mRNA levels in three studied cultures, compared to control cultures. Chronic lithium treatment increased intracellular S100ß protein levels in a cell-type specific manner which may favor its neuroprotective action. The findings of this study suggest that lithium may exert its neuroprotective action, at least partly, by increasing neuronal S100ß level, with no effect on astrocytes or interaction between neurons and astrocytes.
Department of Pharmacology, School of Medicine, Shiraz University of Medical Sciences, Fars, Iran. AND Department of Neuroscience, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Fars, Iran.AND Psychiatric Research Centre, School of Medicine, Shiraz University of Medical Sciences, Fars, Iran. emamm@sums.ac.ir.
Masoumeh
M
Emamghoreishi
Department of Pharmacology, School of Medicine, Shiraz University of Medical Sciences, Fars, Iran. moj.ph60@yahoo.com.
Mojtaba
M
Keshavarz
Department of Pharmacology, School of Medicine, Shiraz University of Medical Sciences, Fars, Iran. nekooeiana@sums.ac.ir.
Ali Akbar
AA
Nekooeian
D000818:Animals; D018692:Antimanic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D001253:Astrocytes / Q000187:drug effects / Q000378:metabolism; D001714:Bipolar Disorder / Q000188:drug therapy / Q000503:physiopathology; D002478:Cells, Cultured; D004797:Enzyme-Linked Immunosorbent Assay; D018020:Lithium Compounds / Q000008:administration & dosage / Q000494:pharmacology*; D009474:Neurons / Q000187:drug effects* / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats
D018692:Antimanic Agents; D018020:Lithium Compounds; D012333:RNA, Messenger